Medicine:Marshall–Smith syndrome

From HandWiki
Marshall-Smith syndrome
Other namesGreig's syndrome, Polysyndactyly cephalopolysyndactyly syndrome, Accelerated skeletal maturation, Marshall-Smith type, Marshall–Smith–Weaver syndrome

Marshall-Smith Syndrome, discovered in 1971 (Marshall, Graham, Scott, Boner, & Smith), is characterized by unusual accelerated skeletal maturation (usually starting before birth) and symptoms like conspicuous physical characteristics, respiratory difficulties, and mental retardation. Cases described in the literature show a clinical variability regarding related symptoms. For instance, respiratory difficulties are ranging from absent to severe difficulties.[1]

Presentation

The syndrome is a rare clinical disorder.[2]

Genotype

The first gene - NFIX - that could cause the syndrome has been identified.[5] This gene is located on the short arm of chromosome 19 (19p13.1).[citation needed]

Diagnosis

Respiratory complications are often cause of death in early infancy.[2]

Differential diagnosis

Marshall–Smith syndrome is not to be confused with:

Terminology

Translated

  • English: Marshall–Smith syndrome
  • Español: Síndrome de Marshall–Smith
  • Français: Le syndrome de Marshall–Smith
  • Italiano: Sindrome di Marshall–Smith
  • Nederlands: Marshall–Smithsyndroom, syndroom van Marshall–Smith
  • Polski: Zespół Marshalla–Smitha, Zespół Marshalla i Smitha
  • Русский: Синдром Маршалла–Смита

References

Further reading

External links

Classification
External resources